Clincosm LogoSign in Get a demo

Urogenital Neoplasms

Showing 1 - 25 of 39
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)

Recruiting
  • Neoplasms
  • +12 more
  • Nanjing, Jiangsu, China
    Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
Oct 28, 2023

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Clinical Significance of Adherent Perinephric Fat in Patients

Recruiting
  • Renal Cell Carcinoma
  • +4 more
    • Otwock, Poland
      European Health Centre, Second Department of Urology, Centre of
    May 31, 2023

    Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Glen Burnie (177Lu-rhPSMA-10.1 injection,

    Recruiting
    • Prostate Cancer
    • +5 more
    • 177Lu-rhPSMA-10.1 injection
    • 18F-rhPSMA-7.3 injection
    • Glen Burnie, Maryland
    • +3 more
    Feb 2, 2023

    Urothelial Cancer and Rare Genitourinary Tract Malignancies

    Recruiting
    • Urothelial Cancer
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Urothelial Cancer, Bladder Cancer, Genitourinary Cancer Trial run by the NCI (M7824, M9241, Stereotactic body radiation therapy

      Recruiting
      • Urothelial Cancer
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Prostatic Tumors, Tumor Metastasis, Urogenital Tumors Trial in Worldwide (Abemaciclib, Abiraterone, Prednisone or Prednisolone)

      Recruiting
      • Prostatic Neoplasms
      • +16 more
      • Birmingham, Alabama
      • +296 more
      Jan 18, 2023

      Prostatic Tumors, Castration-Resistant, Tumors by Histologic Type, Tumors, Prostate Trial in United States (P-PSMA-101 CAR-T

      Active, not recruiting
      • Prostatic Neoplasms, Castration-Resistant
      • +16 more
      • Duarte, California
      • +9 more
      Nov 15, 2022

      Uterine Cervical Tumor, Uterine Tumors, Genital Tumors, Female Trial in Seattle (Usual Care, Education, Direct Mail)

      Active, not recruiting
      • Uterine Cervical Neoplasm
      • +13 more
      • Usual Care
      • +3 more
      • Seattle, Washington
        Kaiser Permanente Washington Health Research Institute
      Aug 16, 2022

      Urogenital Tumors, Drug Therapy Trial in Campinas (Biopsy)

      Completed
      • Urogenital Neoplasms
      • Drug Therapy
      • Biopsy
      • Campinas, SP, Brazil
        Hospital das Clínicas Unicamp
      Jul 7, 2022

      Carcinoma, Ovarian Tumor, Endocrine Gland Tumor Trial in Havana (Ocoxin-Viusid)

      Completed
      • Carcinoma
      • +12 more
      • Ocoxin-Viusid
      • Havana, Cuba
        National Institute of Oncology and Radiobiology (INOR)
      Jul 5, 2022

      Urogenital Tumors Trial (NanoDoce (sterile nanoparticulate docetaxel) Powder for Suspension)

      Available
      • Urogenital Neoplasms
      • NanoDoce (sterile nanoparticulate docetaxel) Powder for Suspension
      • (no location specified)
      Apr 7, 2022

      Prostate Cancer, Prostate Adenocarcinoma, Prostate Cancer Adenocarcinoma Trial in United States (NanoPac (sterile

      Terminated
      Has Results
      • Prostate Cancer
      • +6 more
      • NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension
      • Tampa, Florida
      • +3 more
      Mar 2, 2022

      sidE eFfects of ImmuNotherapy:Possible Clue to Optimize cancEr

      Recruiting
      • Melanoma
      • +4 more
      • Milano, Italy
        Fondazione IRCCS Istituto Nazionale dei Tumori
      Jan 10, 2022

      Bladder Cancer Cell Transitional, Non-Muscle Invasive Bladder Cancer, Bladder Cancer Trial in United States (TSD-001)

      Completed
      • Bladder Cancer Cell Transitional
      • +9 more
      • Tucson, Arizona
      • +4 more
      Jan 18, 2022

      Prostate Tumor, Genital Tumors, Male, Urogenital Tumors Trial in Miami, Chicago (Cultural CBSM, Standard CBSM)

      Recruiting
      • Prostate Neoplasm
      • +5 more
      • Cultural CBSM
      • Standard CBSM
      • Miami, Florida
      • +1 more
      Dec 2, 2021

      Prostate Cancer, Prostatic Tumor, Prostatic Disease Trial in Vancouver ([68Ga]Ga-HTK03149 PET/CT)

      Active, not recruiting
      • Prostate Cancer
      • +5 more
      • [68Ga]Ga-HTK03149 PET/CT
      • Vancouver, British Columbia, Canada
        BC Cancer
      Dec 1, 2021

      Bladder Cancer, Urothelial Carcinoma, Urinary Bladder Tumor Trial in United States (NanoDoce (direct injection), NanoDoce

      Completed
      • Bladder Cancer
      • +8 more
      • NanoDoce (direct injection)
      • +3 more
      • Phoenix, Arizona
      • +4 more
      Nov 29, 2021

      Urothelial Carcinoma, Anlotinib, Urogenital Tumors Trial in Tianjin (Anlotinib, Cisplatin, Carboplatin)

      Not yet recruiting
      • Urothelial Carcinoma
      • +6 more
      • Tianjin, China
        Tianjin Medical Unversity Second Hospital
      Aug 30, 2021

      Urinary Bladder Tumors, Urologic Tumors, Urogenital Tumors Trial in Shanghai (tislelizumab and BCG)

      Recruiting
      • Urinary Bladder Neoplasms
      • +5 more
      • tislelizumab and BCG
      • Shanghai, Shanghai, China
        Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
      Jun 10, 2021

      Urinary Bladder Tumor, Transitional Cell Carcinoma, Urogenital Tumors Trial in Hall In Tirol, Salzburg (Bipolar transurethral

      Recruiting
      • Urinary Bladder Neoplasm
      • +4 more
      • Bipolar transurethral resection of bladder tumor (TURBT)
      • Bipolar transurethral plasma kinetic vaporization of bladder tumor (PKVBT)
      • Hall In Tirol, Austria
      • +1 more
      Mar 19, 2021

      Metastatic Renal Cell Carcinoma, Kidney Tumor, Urologic Tumors Trial in Herlev (Medication (A specification is listed under each

      Recruiting
      • Metastatic Renal Cell Carcinoma
      • +3 more
      • Medication (A specification is listed under each arm)
      • Patient reported outcomes measurement
      • Herlev, Denmark
        Department of Oncology, Herlev and Gentofte Hospital
      Nov 19, 2020

      Ovarian Tumors, Fallopian Tube Tumors, Endocrine Gland Tumors Trial in Nanjing (Niraparib, Bevacizumab)

      Unknown status
      • Ovarian Neoplasms
      • +23 more
      • Nanjing, Jiangsu, China
        JiangSu Cancer Hospital
      Nov 8, 2020

      Ovarian Cancer, Ovarian and Fallopian Tube Cysts and Tumors, Tumors by Site Trial in Nanjing (Anlotinib, Olaparib)

      Recruiting
      • Ovarian Cancer
      • +18 more
      • Nanjing, Jangsu, China
        JiangSu Cancer Hospital
      Oct 29, 2020

      Prostate Cancer, Prostatic Tumor, Urogenital Tumors Trial in Modena ([68Ga]Ga-PSMA-11 PET/CT)

      Recruiting
      • Prostate Cancer
      • +5 more
      • [68Ga]Ga-PSMA-11 PET/CT
      • Modena, Italy
        Azienda Ospedaliero-Universitaria di Modena
      Sep 16, 2020